Clinical Application of Established and Emerging Biomarkers for Cardiopulmonary Diseases
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Laboratory Medicine".
Deadline for manuscript submissions: 10 September 2024 | Viewed by 886
Special Issue Editors
Interests: cardiovascular risk; endothelial function; arterial stiffness; atherosclerosis; COVID-19; chronic obstructive pulmonary disease; asthma; biomarkers; rehabilitation; chronic disease
Special Issues, Collections and Topics in MDPI journals
2. Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy
Interests: chronic obstructive pulmonary disease; severe asthma; nitric oxide; biomarkers; metabolomics; exhaled breath condensate
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With a worldwide prevalence of 7.4%, chronic respiratory conditions have a growing impact at all levels of economic and health systems, relevant social costs, and new healthcare needs in a population that is increasingly living longer. The impact of cardiovascular diseases appears to be even more significant, as stated by the World Health Organization (WHO), which reports that they are the leading cause of death worldwide, claiming an estimated 17.9 million lives each year. The close interconnection between respiratory and cardiovascular pathologies has recently become an area of great clinical and scientific interest, increasing the need for new diagnostic and prognostic tools for the adequate assessment of comorbidities and overall clinical complexity.
Using both clinical methods and laboratory analyses of biological matrices, an increasing number of biomarkers have been identified to improve the risk stratification and adequate monitoring of the pharmacological and rehabilitative therapies recommended in cardiopulmonary diseases.
Using both clinical methods and laboratory analyses of biological matrices, an increasing number of biomarkers have been identified in order to improve the risk stratification and adequate monitoring of the pharmacological as well as rehabilitative therapies recommended in respiratory diseases.
This Special Issue aims to collect new evidence on the use of established and emerging biomarkers for cardiopulmonary diseases, which include, but are not limited, to severe asthma, chronic obstructive pulmonary disease, interstitial lung disease, heart failure, myocardial infarction, and stroke.
This collection of articles will cover original Articles and Reviews, and it will be open to both clinical and functional studies disclosing new prognostic and diagnostic applications of existing and novel biomarkers.
Dr. Pasquale Ambrosino
Prof. Dr. Mauro Maniscalco
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic obstructive pulmonary disease
- severe asthma
- biomarkers
- metabolomics
- endothelial function
- arterial stiffness
- cardiovascular risk
